The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors

por Ling, Ann Wan-Chin, Chan, Cze-Ci, Chen, Shao-Wei, Kao, Yi-Wei, Huang, Chien-Ying, Chan, Yi-Hsin, Chu, Pao-Hsien
Publicado 2020